BIO Stock Overview
Biogena Group Invest AG engages in the provision of dietary supplements. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Biogena Group Invest Ag Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.65 |
| 52 Week High | €2.50 |
| 52 Week Low | €1.40 |
| Beta | 0 |
| 11 Month Change | 4.43% |
| 3 Month Change | -16.24% |
| 1 Year Change | -28.26% |
| 33 Year Change | -47.62% |
| 5 Year Change | n/a |
| Change since IPO | -57.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIO | AT Personal Products | AT Market | |
|---|---|---|---|
| 7D | -9.3% | -1.6% | 0.7% |
| 1Y | -28.3% | -6.0% | 2.0% |
Return vs Industry: BIO underperformed the Austrian Personal Products industry which returned -6% over the past year.
Return vs Market: BIO underperformed the Austrian Market which returned 1.5% over the past year.
Price Volatility
| BIO volatility | |
|---|---|
| BIO Average Weekly Movement | 9.6% |
| Personal Products Industry Average Movement | 3.8% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.4% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: BIO's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: BIO's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | biogenagroup.com |
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
Biogena Group Invest Ag Fundamentals Summary
| BIO fundamental statistics | |
|---|---|
| Market cap | €6.38m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIO income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BIO perform over the long term?
See historical performance and comparison